Craft

CollPlant

Stock Price

$3.9

2024-10-29

Market Capitalization

$44.9 M

2024-10-29

Revenue

$2.4 M

FY, 2025

CollPlant Summary

Company Summary

Overview
CollPlant Biotechnologies is a medicine company that specializes in tissue regeneration and organ manufacturing. Its products include dermal fillers; breast implants; Collink.3D Bioinks; Vergenix FG, an advanced wound-care device; Vergenix STR, a soft tissue repair matrix mixed with PRP, etc. The company also specializes in rhCollagen and 3D bioprinting technologies.
Type
Public
Status
Active
Founded
1981
HQ
Rehovot, IL | view all locations
Website
https://www.collplant.com
Cybersecurity rating
Sectors

Key People

  • Yehiel Tal

    Yehiel Tal, Chief Executive Officer

    • Abraham Havron, Director

      • Oded Shoseyov

        Oded Shoseyov, Founder and Chief Scientist

        • Hugh Evans, Director

          LocationsView all

          1 location detected

          • Rehovot, Tel Aviv District HQ

            Israel

            4 Oppenheimer Street

          CollPlant Financials

          Summary Financials

          Revenue (Q1, 2026)
          $73.0K
          Gross profit (Q1, 2026)
          ($243.0K)
          Net income (Q1, 2026)
          ($3.1M)
          Cash (Q1, 2026)
          $4.3M
          EBIT (Q1, 2026)
          ($3.1M)

          Footer menu